Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence of the carbapenem-heteroresistant phenotype among ESBL-producing Escherichia coli and Klebsiella pneumoniae clinical isolates.

The Journal of antimicrobial chemotherapy - 1 Jun 2020

Tan Karen, Nguyen James, Nguyen Kevin, Huse Holly K, Nieberg Paul H, Wong-Beringer Annie

Abstract excerpt

OBJECTIVES: Carbapenem-heteroresistant (cHR) Enterobacteriaceae strains have been reported worldwide; however, the prevalence among clinical ESBL-producing Enterobacteriaceae isolates obtained from patients with repeated hospital admissions remains largely unknown. METHODS: Heteroresistance was screened by disc diffusion and confirmed by a modified population analysis profiling (PAP) method against ertapenem,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Bacterial Agents
Share to beta-Lactamases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carbapenems

Share to Escherichia coli

Share to Klebsiella pneumoniae

Share to Microbial Sensitivity Tests

Share to Phenotype

Share to Prevalence

Source

Identifiers

PMID: 32181802
DOI: 10.1093/jac/dkaa048

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence of the carbapenem-heteroresistant phenotype among ESBL-producing Escherichia coli and Klebsiella pneumoniae clinical isolates.PMID 32181802Read ↗

Rates of resistance and heteroresistance to newer β-lactam/β-lactamase inhibitors for carbapenem-resistant EnterobacteralesSemantic proximity Read ↗

Impact of carbapenem heteroresistance among clinical isolates of invasive Escherichia coli in Chongqing, southwestern China.Semantic proximity Read ↗

Frequency of cefiderocol heteroresistance among patients treated with cefiderocol for carbapenem-resistant Acinetobacter baumannii infectionsSemantic proximity Read ↗

Heteroresistance to Amikacin in Carbapenem-Resistant Klebsiella pneumoniae StrainsSemantic proximity Read ↗

Multicenter Study of Colistin Heteroresistance in Carbapenem-Resistant Klebsiella pneumoniae Strains in ChinaSemantic proximity Read ↗

Emergence of heteroresistance to carbapenems in Gram-negative clinical isolates from two Egyptian hospitals.Semantic proximity Read ↗

Heteroresistance to cefiderocol in carbapenem-resistant Acinetobacter baumannii in the CREDIBLE-CR study was not linked to clinical outcomes: a post hoc analysisSemantic proximity Read ↗

Carbapenem-resistant Gram-negative bacteria exhibiting clinically undetected cefiderocol heteroresistance leads to treatment failure in a murine model of infectionSemantic proximity Read ↗

Bacteraemia with an MBL-producing Klebsiella pneumoniae : treatment and the potential role of cefiderocol heteroresistanceSemantic proximity Read ↗

Overexpression of KPC contributes to ceftazidime-avibactam heteroresistance in clinical isolates of carbapenem-resistant Klebsiella pneumoniaeSemantic proximity Read ↗

Epidemiological and clinical features for cefepime heteroresistant Escherichia coli infections in Southwest China.Semantic proximity Read ↗

Characteristics of Meropenem Heteroresistance in Klebsiella pneumoniae Carbapenemase (KPC)-Producing Clinical Isolates of K. pneumoniaeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.